[Use of decamethoxine in the complex treatment of chronic bronchitis].
Seventy-two patients with chronic bronchitis were examined and divided into 3 groups. Group I consisted of patients with chronic catarrhal bronchitis (CCB) group II of those with chronic purulent bronchitis (CPB), group III of subjects with bronchitis associated with purulent destructive pulmonary diseases. All the patients received combined treatment with decamethoxin as an antibacterial modality. It was found that decamethoxin promotes elimination of the infection of the bronchial secretion in 60% of chronic bronchitis suffers, the incidence of microorganisms resistent to several antibiotics reduced 2-fold. Local use of decamethoxin as an antibacterial and antiinflammatory drug in multimodality treatment of chronic purulent bronchitis proved highly effective.
Iukhimets
V A
VA
Pilipchuk
V N
VN
D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003650:Decamethonium Compounds / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005100:Expectorants / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D001993:Bronchodilator Agents; D003650:Decamethonium Compounds; D005100:Expectorants; C000858:decamethoxine
Primenenie dekametoksina v kompleksnom lechenii khronicheskogo bronkhita.